Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2010, Article ID 353679, 3 pages
http://dx.doi.org/10.1155/2010/353679
Case Report

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine College of Medicine, Orange, CA 92868, USA

Received 2 September 2009; Revised 24 March 2010; Accepted 8 April 2010

Academic Editor: Michael Leahy

Copyright © 2010 Nefertiti Chianti duPont and Philip John DiSaia. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Doran and C. Lockyer, “Two cases of uterine fibroids showing peritheliomatous changes; long immunity from recurrence after operation,” Proceedings of the Royal Society of Medicine, vol. 2, no. 25, pp. 25–39, 1908. View at Google Scholar
  2. J. R. Goodall, “Endometrioma interstitiale: a preliminary report,” The Journal of Obstetrics and Gynaecology of the British Empire, vol. 47, no. 1, pp. 13–39, 1940. View at Google Scholar
  3. A. Berchuck, S. C. Rubin, W. J. Hoskins, P. E. Saigo, V. K. Pierce, and J. L. Lewis Jr., “Treatment of endometrial stromal tumors,” Gynecologic Oncology, vol. 36, no. 1, pp. 60–65, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. Norris and H. B. Taylor, “Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors,” Cancer, vol. 19, no. 6, pp. 755–766, 1966. View at Google Scholar · View at Scopus
  5. M. C. Chu, G. Mor, C. Lim, W. Zheng, V. Parkash, and P. E. Schwartz, “Low-grade endometrial stromal sarcoma: hormonal aspects,” Gynecologic Oncology, vol. 90, no. 1, pp. 170–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. L. Kempson and M. R. Hendrickson, “Smooth muscle, endometrial stromal, and mixed Müllerian tumors of the uterus,” Modern Pathology, vol. 13, no. 3, pp. 328–342, 2000. View at Google Scholar · View at Scopus
  7. F. Amant, P. Moerman, I. Cadron, P. Neven, P. Berteloot, and I. Vergote, “The diagnostic problem of endometrial stromal sarcoma: report on six cases,” Gynecologic Oncology, vol. 90, no. 1, pp. 37–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Riopel, M. Plante, M.-C. Renaud, M. Roy, and B. Têtu, “Lymph node metastases in low-grade endometrial stromal sarcoma,” Gynecologic Oncology, vol. 96, no. 2, pp. 402–406, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. K. Chan, N. M. Kawar, J. Y. Shin, K. Osann, L.-M. Chen, C. B. Powell, and D. S. Kapp, “Endometrial stromal sarcoma: a population-based analysis,” British Journal of Cancer, vol. 99, no. 8, pp. 1210–1215, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. A. Leath III, W. K. Huh, and W. K. Huh , “A multi-institutional review of outcomes of endometrial stromal sarcoma,” Gynecologic Oncology, vol. 105, no. 3, pp. 630–634, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. Katz, M. J. Merino, H. Sakamoto, and P. E. Schwartz, “Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors,” Gynecologic Oncology, vol. 26, no. 1, pp. 87–97, 1987. View at Google Scholar · View at Scopus
  12. M. Lantta, K. Kahanpää, J. Kärkkäinen, P. Lehtovirta, T. Wahlström, and O. Widholm, “Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma,” Gynecologic Oncology, vol. 18, no. 2, pp. 233–239, 1984. View at Google Scholar · View at Scopus
  13. X.-Q. Zhu, Y.-F. Shi, X.-D. Cheng, C.-L. Zhao, and Y.-Z. Wu, “Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma,” Gynecologic Oncology, vol. 92, no. 1, pp. 71–79, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell, “The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding,” Molecular and Cellular Biology, vol. 20, no. 9, pp. 3102–3115, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. D. G. Mutch, “The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas,” Gynecologic Oncology, vol. 115, no. 3, pp. 325–328, 2009. View at Google Scholar
  16. D. R. Scribner Jr. and J. L. Walker, “Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace,” Gynecologic Oncology, vol. 71, no. 3, pp. 458–460, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Leunen, M. Breugelmans, Ph. De Sutter, C. Bourgain, and J. J. Amy, “Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole,” Gynecologic Oncology, vol. 95, no. 3, pp. 769–771, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. C. Burke and K. Hickey, “Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue,” Obstetrics and Gynecology, vol. 104, no. 5, part 2, pp. 1182–1184, 2004. View at Google Scholar · View at Scopus
  19. J. L. Mansi, S. Ramachandra, E. Wiltshaw, and C. Fisher, “Endometrial stromal sarcomas,” Gynecologic Oncology, vol. 36, no. 1, pp. 113–118, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-P. Spano, J.-C. Soria, M. Kambouchner et al., “Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma,” Medical Oncology, vol. 20, no. 1, pp. 87–93, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. S. Piver, F. N. Rutledge, L. Copeland, K. Webster, L. Blumenson, and O. Suh, “Uterine endolymphatic stromal myosis: a collaborative study,” Obstetrics and Gynecology, vol. 64, no. 2, pp. 173–178, 1984. View at Google Scholar · View at Scopus
  22. Y. Matsuura, K. Yasunaga, H. Kuroki, H. Inagaki, and M. Kashimura, “Low-grade endometrial stromal sarcoma recurring with multiple bone and lung metastases: report of a case,” Gynecologic Oncology, vol. 92, no. 3, pp. 995–998, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. Y. Yokoyama, Y. Ono, T. Sakamoto, I. Fukuda, and H. Mizunuma, “Asymptomatic intracardiac metastasis from a low-grade endometrial stromal sarcoma with successful surgical resection,” Gynecologic Oncology, vol. 92, no. 3, pp. 999–1001, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. C. Maluf, P. Sabbatini, L. Schwartz, J. Xia, and C. Aghajanian, “Endometrial stromal sarcoma: objective response to letrozole,” Gynecologic Oncology, vol. 82, no. 2, pp. 384–388, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. P. Dombernowsky, I. Smith, G. Falkson et al., “Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate,” Journal of Clinical Oncology, vol. 16, no. 2, pp. 453–461, 1998. View at Google Scholar · View at Scopus
  26. F. Amant, A. Coosemans, M. Debiec-Rychter, D. Timmerman, and I. Vergote, “Clinical management of uterine sarcomas,” The Lancet Oncology, vol. 10, no. 12, pp. 1188–1198, 2009. View at Publisher · View at Google Scholar · View at Scopus